Clinical Trial Update: Assessment of the Rosacea Prevalence in the General Population

View source ↗

Summary

A completed clinical trial update assessing the prevalence of rosacea in the general population, sponsored by Galderma R&D.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rosacea

Snippet

Sponsor: Galderma R&D | Conditions: Rosacea | Status: COMPLETED